Hyaluronate Sodium
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB08818 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 100 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | dry eye syndrome | KG + DL |
| 2 | Sjogren syndrome | KG + DL |
| 3 | xerophthalmia | KG + DL |
| 4 | psoriasis | KG + DL |
| 5 | dermatitis, atopic | KG + DL |
| 6 | prolapse of lacrimal gland | KG + DL |
| 7 | parapsoriasis | KG + DL |
| 8 | pityriasis lichenoides | KG + DL |
| 9 | severe nonproliferative diabetic retinopathy | KG + DL |
| 10 | exanthem (disease) | KG + DL |
| 11 | acute lichenoid pityriasis | KG + DL |
| 12 | diabetic retinopathy | KG + DL |
| 13 | disorder of lacrimal gland | KG + DL |
| 14 | excretory apparatus of the lacrimal system anomaly | KG + DL |
| 15 | nasolacrimal duct disease | KG + DL |
| 16 | dermatitis | KG + DL |
| 17 | lacrimal passage granuloma | KG + DL |
| 18 | stenosis of lacrimal sac | KG + DL |
| 19 | eversion of lacrimal punctum | KG + DL |
| 20 | secretory apparatus of the lacrimal system anomaly | KG + DL |
| 21 | lacrimal atrophy | KG + DL |
| 22 | brain aneurysm | KG + DL |
| 23 | anomaly of the secretory and excretory apparatus of the lacrimal system | KG + DL |
| 24 | excessive tearing | KG + DL |
| 25 | esotropia | KG + DL |
| 26 | congenital ichthyosiform erythroderma | KG + DL |
| 27 | psoriasis 14, pustular | KG + DL |
| 28 | alopecia areata | KG + DL |
| 29 | fetal erythroblastosis | KG + DL |
| 30 | pustulosis palmaris et plantaris | KG + DL |
| 31 | aphthous stomatitis | KG + DL |
| 32 | lacrimal gland neoplasm | KG + DL |
| 33 | anaphylaxis | KG + DL |
| 34 | acne keloid | KG + DL |
| 35 | amyopathic dermatomyositis | KG + DL |
| 36 | acrodermatitis chronica atrophicans | KG + DL |
| 37 | hereditary hypotrichosis with recurrent skin vesicles | KG + DL |
| 38 | anorectal stricture | KG + DL |
| 39 | neonatal dermatomyositis | KG + DL |
| 40 | Quinquaud’s folliculitis decalvans | KG + DL |
| 41 | secondary interstitial lung disease specific to childhood associated with a connective tissue disease | KG + DL |
| 42 | imperforate anus | KG + DL |
| 43 | alopecia universalis onychodystrophy vitiligo | KG + DL |
| 44 | alopecia antibody deficiency | KG + DL |
| 45 | alopecia-intellectual disability-hypergonadotropic hypogonadism syndrome | KG + DL |
| 46 | proctitis | KG + DL |
| 47 | alopecia mucinosa | KG + DL |
| 48 | telogen effluvium | KG + DL |
| 49 | anal polyp | KG + DL |
| 50 | hydroa vacciniforme, familial | KG + DL |
(Showing top 50 of 100 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.